Nautilus Biotechnolgy, Inc. (NAUT)
$2.17-3.56%Close
BUYRECOVERY · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $276M
- Beta
- 0.87
- P/E (TTM)
- -3.93
- Short % float
- 10.34%
- Days to cover
- 1.4
- SI change
- +41.4%
- 1W
- +16.04%
- 1M
- +112.75%
- vs SPY 1W
- +15.62%
- vs SPY 1M
- +110.68%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on NAUT?
- LOPJLB’s latest quantitative signal on Nautilus Biotechnolgy, Inc. (NAUT) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is NAUT in?
- Nautilus Biotechnolgy, Inc. (NAUT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Nautilus Biotechnolgy, Inc. (NAUT) do?
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrumen…